Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology



Chapter 2. Executive Summary


2.1. Global automated colony counter market, 2014 2024 (USD Million)

2.2. Global automated colony counter market: Snapshot



Chapter 3. Automated colony counter Market Dynamics


3.1. Introduction

3.2. Market drivers


3.2.1. Increasing laboratory automation

3.2.2. Rising incidence of infectious diseases and growing outbreaks of epidemics

3.3. Market Restraints


3.3.1. High cost of Automated counter

3.4. Opportunities


3.4.1. Rising incidence of infectious diseases and growing outbreaks of epidemics

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat of new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by application segment

3.6.2. Market attractiveness analysis, by End-users segment

3.6.3. Market attractiveness analysis, by regional segment



Chapter 4. Global Automated colony counter market Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global automated colony counter market: company market share, 2014

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Therapy Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, Therapy and Regional Expansion



Chapter 5. Global Automated colony counter market Application Segment Analysis


5.1. Global automated colony counter market: Application type overview


5.1.1. Global automated colony counter market revenue share, by application, 2014 and 2024

5.2. Microbiology studies


5.2.1. Global Microbiology studies market, 2014 2024(USD Million)

5.3. Antibiotic testing


5.3.1. Global Antibiotic testing market, 2014 2024(USD Million)

5.4. Fluids contamination


5.4.1. Global Fluids contamination market, 2014 2024(USD Million)

5.5. Hygiene studies


5.5.1. Global Hygiene studies market, 2014 2024(USD Million)

5.6. GFP Colonies


5.6.1. Global GFP Colonies market, 2014 2024(USD Million)



Chapter 6. Global Automated colony counter market End-user Segment Analysis


6.1. Global automated colony counter market: End-use overview


6.1.1. Global automated colony counter market revenue share, by End-user, 2014 2024

6.2. Medical Labs


6.2.1. Global automated colony counter market for Medical Labs, 2014 2024 (USD Million)

6.3. Scientific Research Labs


6.3.1. Global automated colony counter market for Scientific Research Labs, 2014 2024 (USD Million)

6.4. Industries


6.4.1. Global automated colony counter market for Industries, 2014 2024 (USD Million)

6.5. Other


6.5.1. Global automated colony counter market for Other, 2014 2024 (USD Million)



Chapter 7. Global Automated colony counter market Regional Segment Analysis


7.1. Global automated colony counter market: Regional overview


7.1.1. Global automated colony counter market revenue share, by region, 2014 and 2024

7.2. North America


7.2.1. North America automated colony counter market revenue, by application, 2014 2024 (USD Million)

7.2.2. North America automated colony counter market revenue, by end-users, 2014 2024 (USD Million)

7.2.3. North America automated colony counter market revenue, by Country, 2014 2024 (USD Million)

7.2.4. U.S.

7.2.5. Rest Of America

7.3. Europe


7.3.1. Europe automated colony counter market revenue, by application, 2014 2024(USD Million)

7.3.2. Europe automated colony counter market revenue, by end-user, 2014 2024(USD Million)

7.3.3. Europe automated colony counter market revenue, by Country, 2014 2024(USD Million)

7.3.4. Germany

7.3.5. UK

7.3.6. France

7.3.7. Italy

7.3.8. Spain

7.3.9. Russia

7.3.10. Rest of Europe

7.4. Asia Pacific


7.4.1. Asia Pacific automated colony counter market revenue, by application, 2014 2024, (USD Million)

7.4.2. Asia Pacific automated colony counter market revenue, by end-user, 2014 2024(USD Million)

7.4.3. Asia Pacific automated colony counter market revenue, by Country, 2014 2024(USD Million)

7.4.4. China

7.4.5. Japan

7.4.6. India

7.4.7. Australia

7.4.8. Rest of Asia Pacific

7.5. Latin America


7.5.1. Latin America automated colony counter market revenue, by application, 2014 2024(USD Million)

7.5.2. Latin America automated colony counter market revenue, by end-user, 2014 2024(USD Million)

7.5.3. Latin America automated colony counter market revenue, by end-user, 2014 2024(USD Million)

7.5.4. Brazil

7.5.5. Rest of Latin America

7.6. Middle East and Africa


7.6.1. Middle East and Africa automated colony counter market revenue, by application, 2014 2024 (USD Million)

7.6.2. Middle East and Africa automated colony counter market revenue, by end-user, 2014 2024(USD Million)

7.6.3. Middle East and Africa automated colony counter market revenue, by end-user, 2014 2024(USD Million)



Chapter 8. Company Profile


8.1. bioMrieux, Inc.


8.1.1. Overview

8.1.2. Financials

8.1.3. Therapy portfolio

8.1.4. Business strategy

8.1.5. Recent developments

8.2. BIOAVLEE Sp.


8.2.1. Overview

8.2.2. Financials

8.2.3. Therapy portfolio

8.2.4. Business strategy

8.2.5. Recent developments

8.3. AutoimmunDiagnostika GmbH


8.3.1. Overview

8.3.2. Financials

8.3.3. Therapy portfolio

8.3.4. Business strategy

8.3.5. Recent developments

8.4. INTERSCIENCE


8.4.1. Overview

8.4.2. Financials

8.4.3. Therapy portfolio

8.4.4. Business strategy

8.4.5. Recent developments

8.5. Molecular Devices, LLC.


8.5.1. Overview

8.5.2. Financials

8.5.3. Therapy portfolio

8.5.4. Business strategy

8.5.5. Recent developments

8.6. Neu-tec Group Inc.


8.6.1. Overview

8.6.2. Financials

8.6.3. Therapy portfolio

8.6.4. Business strategy

8.6.5. Recent developments

8.7. Suntex Instruments Co., Ltd


8.7.1. Overview

8.7.2. Financials

8.7.3. Therapy portfolio

8.7.4. Business strategy

8.7.5. Recent developments

8.8. Boeckel Co (GmbH Co.) KG


8.8.1. Overview

8.8.2. Financials

8.8.3. Therapy portfolio

8.8.4. Business strategy

8.8.5. Recent developments

8.9. Labline Stock Centre


8.9.1. Overview

8.9.2. Financials

8.9.3. Therapy portfolio

8.9.4. Business strategy

8.9.5. Recent developments

8.10. PATEL SCIENTIFIC INSTRUMENTS PVT LTD


8.10.1. Overview

8.10.2. Financials

8.10.3. Therapy portfolio

8.10.4. Business strategy

8.10.5. Recent developments

8.11. SM Scientific Instruments Pvt. Ltd.


8.11.1. Overview

8.11.2. Financials

8.11.3. Therapy portfolio

8.11.4. Business strategy

8.11.5. Recent developments

8.12. Spectronics India


8.12.1. Overview

8.12.2. Financials

8.12.3. Therapy portfolio

8.12.4. Business strategy

8.12.5. Recent developments

8.13. Synbiosis, A Division of Synoptics Ltd


8.13.1. Overview

8.13.2. Financials

8.13.3. Therapy portfolio

8.13.4. Business strategy

8.13.5. Recent developments

8.14. UVP, LLC (DBA Analytik Jena US)


8.14.1. Overview

8.14.2. Financials

8.14.3. Therapy portfolio

8.14.4. Business strategy

8.14.5. Recent developments

8.15. Xylem Analytics Germany Sales GmbH Co. KG.


8.15.1. Overview

8.15.2. Financials

8.15.3. Therapy portfolio

8.15.4. Business strategy

8.15.5. Recent developments

8.16. ZENITH ENGINEERS (Biozen)


8.16.1. Overview

8.16.2. Financials

8.16.3. Therapy portfolio

8.16.4. Business strategy

8.16.5. Recent developments